FDA grants tentative approval for DAPAGLIFLOZIN from SCIEGEN PHARMACEUTICALS INC
Tentative approval of ANDA #ANDA #219408 for DAPAGLIFLOZIN. Decision date: 01/08/2026
Tentative approval of ANDA #ANDA #219408 for DAPAGLIFLOZIN. Decision date: 01/08/2026
There are no comments here yet...